Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2026
Percheron Therapeutics appoints Michael Baker as CEO
Percheron Therapeutics appointed Dr Michael Baker as managing director and chief executive officer. He is due to take up the role on October 5, 2026, succeeding Dr James Garner.
2026
James Garner to step down as Percheron CEO
Dr James Garner will step down as CEO and managing director of Percheron Therapeutics on August 31, 2026, and pursue a new professional opportunity overseas. He will remain on the company's board as a non-executive director from September 1.